CC-91633 (BMS-986397)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CC-91633 (BMS-986397), covering 2025-08-27 to 2025-08-27. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate Safety and Tolerability of CC-91633 (BMS-986397) in Participants With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher-Risk Myelodysplastic Syndromes [Phase 1]